HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aspirin in the secondary prevention of unprovoked thromboembolism: the WARFASA and ASPIRE studies.

AuthorsSimone Birocchi, Emanuela Scannella, Laura Ferrari, Gian Marco Podda, Gruppo di Autoformazione Metodologica (GrAM)
JournalInternal and emergency medicine (Intern Emerg Med) Vol. 8 Issue 8 Pg. 757-60 (Dec 2013) ISSN: 1970-9366 [Electronic] Italy
PMID23744554 (Publication Type: Journal Article)
Chemical References
  • Anticoagulants
  • Fibrinolytic Agents
  • Warfarin
  • Aspirin
Topics
  • Anticoagulants (therapeutic use)
  • Aspirin (therapeutic use)
  • Fibrinolytic Agents (therapeutic use)
  • Humans
  • Randomized Controlled Trials as Topic
  • Secondary Prevention
  • Thromboembolism (prevention & control)
  • Warfarin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: